JAK2 and lung carcinoma: Moreover, we show that SH2B3 binds to JAK2 to inhibit JAK2/STAT3 signaling, supporting that hyperactivity of JAK2/STAT3 signaling in lung cancer cells results from diminished SH2B3 expression level.